PDUFA Dates December 2022
A PDUFA date is the FDA’s target deadline to complete its review of a drug application under the Prescription Drug User Fee Act. Approval, a Complete Response Letter, or a delay on this date is one of the largest single-day catalysts a biotech stock has. Dates below are extracted from company 8-K filings and official notices, with the source linked on every event.
No confirmed PDUFA decision events tracked for December 2022 yet. PDUFA dates surface when companies disclose them in filings — check back, or watch the 14-day window.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.